EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza

Alison C West, Christopher M Harpur, Mélanie A Le Page, Maggie Lam, Christopher Hodges, Lauren K Ely, Andrew J Gearing, Michelle D Tate iD

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad566 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Alison C West und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research. Hauptthemen laut MEDLINE: Orthomyxoviridae Infections, Disease Models, Animal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Excessive pulmonary inflammation and damage are characteristic features of severe influenza virus infections. LAT8881 is a synthetic 16–amino acid cyclic peptide form of a naturally occurring C-terminal fragment of human growth hormone with therapeutic efficacy against influenza. Shorter linear peptides are typically easier to manufacture and formulate for delivery than larger cyclic peptides. A 6–amino acid linear peptide fragment of LAT8881, LAT9997, was investigated as a potential influenza therapy.

Methods

LAT9997 was evaluated for its potential to limit disease in a preclinical mouse model of severe influenza infection.

Results

Intranasal treatment of mice with either LAT8881 or LAT9997 from day 1 following influenza infection significantly improved survival outcomes. Initiating LAT9997 treatment at the onset of severe disease also significantly improved disease severity. Greater disease resistance in LAT9997-treated mice correlated with reduced lung immunopathology, damage markers, vascular leak, and epithelial cell death. Treatment reduced viral loads, cytokines, and neutrophil infiltration in the airways yet maintained protective alveolar macrophages in a dose-dependent manner. Sequential trimming of N- and C-terminal amino acids from LAT9997 revealed a structure-activity relationship.

Conclusions

These findings provide preclinical evidence that therapeutic LAT9997 treatment limits viral burden and characteristic features of severe influenza, including hyperinflammation and lung damage. Summary Excessive pulmonary inflammation and damage are characteristic features of severe influenza virus infections. LAT9997 is a linear peptide fragment derived from human growth hormone. This study provides preclinical evidence that therapeutic LAT9997 treatment limits viral burden, hyperinflammation, and lung damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Orthomyxoviridae InfectionsDisease Models, AnimalAnimalsMiceLungFemaleAntiviral AgentsCytokinesViral LoadHumansPeptides, CyclicInfluenza, HumanAdministration, IntranasalPeptide Fragments

Stichwörter der Autor:innen

cytokinehost-directed therapyinfluenza viruspulmonary disease

Substanzen

Antiviral AgentsCytokinesPeptides, CyclicPeptide Fragments

Autor:innen und Institutionen

  • Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research.
  • Department of Molecular and Translational Sciences, Monash University, Clayton.
  • Lateral Pharma Pty Ltd, Melbourne, Australia.

ORCID-Profile: Michelle D Tate

Zitieren

APA

West, A. C., Harpur, C. M., Le Page, M. A., Lam, M., Hodges, C., Ely, L. K., Gearing, A. J., & Tate, M. D. (2024). Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad566

Vancouver

West AC, Harpur CM, Le Page MA, Lam M, Hodges C, Ely LK, et al. Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad566

BibTeX
@article{West2024,
  author = {West, Alison C and Harpur, Christopher M and Le Page, Mélanie A and Lam, Maggie and Hodges, Christopher and Ely, Lauren K and Gearing, Andrew J and Tate, Michelle D},
  title = {Harnessing Endogenous Peptide Compounds as Potential Therapeutics for Severe Influenza},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad566}
}
Kostenlos starten →